Enveric Biosciences Faces Delisting Notice
Ticker: ENVB · Form: 8-K · Filed: Nov 22, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Nov 22, 2024 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $1.00 b, $5,000,000 m |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
Enveric Biosciences got a notice about failing to meet listing rules - could get delisted.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on November 20, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in Naples, Florida, and its principal executive offices are located at 4851 Tamiami Trail N, Suite 200.
Why It Matters
This filing indicates potential issues with Enveric Biosciences' compliance with stock exchange listing standards, which could lead to the company's shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and investor confidence.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 4851 Tamiami Trail N, Suite 200 Naples, FL 34103 (location) — Principal executive offices
- November 20, 2024 (date) — Date of earliest event reported
FAQ
What is the specific reason for Enveric Biosciences' notice of delisting or failure to satisfy a continued listing rule?
The provided text states that the company received a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard that was not met.
When was this notice of delisting filed?
The Form 8-K reporting this notice was filed on November 22, 2024, and the earliest event reported is dated November 20, 2024.
What is Enveric Biosciences' primary business or industry?
Enveric Biosciences, Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Where are Enveric Biosciences' principal executive offices located?
The company's principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the Commission File Number for Enveric Biosciences?
The Commission File Number for Enveric Biosciences, Inc. is 001-38286.
Filing Stats: 778 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2024-11-22 16:45:11
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
- $1.00 b — sted Shares") no longer met the minimum $1.00 bid price per share requirement for the c
- $5,000,000 m — sion because it did not comply with the $5,000,000 minimum stockholders' equity initial list
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-047420.txt ( ) — 210KB
- envb-20241120.xsd (EX-101.SCH) — 3KB
- envb-20241120_lab.xml (EX-101.LAB) — 33KB
- envb-20241120_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 22, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer